Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 16 studies | 29% ± 9% | |
smooth muscle cell | 11 studies | 25% ± 8% | |
fibroblast | 4 studies | 17% ± 2% | |
hematopoietic precursor cell | 3 studies | 16% ± 0% | |
abnormal cell | 3 studies | 17% ± 0% | |
epithelial cell | 3 studies | 35% ± 11% | |
endothelial cell | 3 studies | 23% ± 6% | |
neuron | 3 studies | 38% ± 20% | |
connective tissue cell | 3 studies | 22% ± 1% | |
erythroblast | 3 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 3516.96 | 180 / 180 | 99% | 80.28 | 426 / 430 |
prostate | 100% | 6190.56 | 245 / 245 | 98% | 32.01 | 494 / 502 |
uterus | 100% | 2674.19 | 170 / 170 | 98% | 67.16 | 451 / 459 |
bladder | 100% | 3296.76 | 21 / 21 | 98% | 60.58 | 495 / 504 |
esophagus | 100% | 3653.50 | 1445 / 1445 | 98% | 44.60 | 179 / 183 |
lung | 99% | 2894.97 | 574 / 578 | 98% | 44.25 | 1135 / 1155 |
skin | 100% | 4866.65 | 1808 / 1809 | 97% | 51.23 | 456 / 472 |
thymus | 100% | 2350.15 | 652 / 653 | 96% | 33.76 | 583 / 605 |
intestine | 97% | 1412.66 | 941 / 966 | 98% | 47.97 | 517 / 527 |
breast | 100% | 2323.22 | 458 / 459 | 94% | 36.08 | 1054 / 1118 |
brain | 94% | 1669.84 | 2482 / 2642 | 99% | 51.95 | 695 / 705 |
adrenal gland | 100% | 5048.93 | 258 / 258 | 88% | 174.09 | 203 / 230 |
stomach | 77% | 973.02 | 276 / 359 | 98% | 46.12 | 280 / 286 |
kidney | 97% | 1937.96 | 86 / 89 | 72% | 16.34 | 651 / 901 |
pancreas | 55% | 512.48 | 180 / 328 | 97% | 39.91 | 173 / 178 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 92.86 | 1 / 1 |
blood vessel | 100% | 3302.58 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 2327.16 | 1194 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 4587.82 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 30.39 | 76 / 80 |
spleen | 93% | 1486.51 | 225 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 33.88 | 24 / 29 |
liver | 11% | 129.50 | 24 / 226 | 45% | 14.21 | 183 / 406 |
peripheral blood | 37% | 1022.11 | 340 / 929 | 0% | 0 | 0 / 0 |
muscle | 29% | 259.35 | 235 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008253 | Molecular function | 5'-nucleotidase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NT5DC2 |
Protein name | 5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-) 5'-nucleotidase domain containing 2 |
Synonyms | |
Description | |
Accessions | ENST00000463947.5 ENST00000459839.5 [Q9H857-3] ENST00000492555.5 C9J036 H7C4G8 Q9H857 ENST00000422318.7 [Q9H857-2] ENST00000489316.5 ENST00000471522.5 H7C519 F8WEY1 ENST00000307076.8 [Q9H857-1] |